-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say. On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...
More »SEARCH RESULT
Novartis vs India: the showdown approaches by Simon Reid-Henry
The Swiss-based pharmaceutical giant Novartis is taking the state of India to court in a case that has, after rumbling about in the lower courts for six years, wound up as a very public litmus test of the legal framework sustaining India’s generic drugs revolution. With the case due before the Supreme Court on 28 March, the fate of millions who depend on affordable Indian medicines may soon hang in the...
More »Censoring the Internet: The New Intermediary Guidelines by Rishab Bailey
The government’s recent actions in notifying the Intermediary Guidelines for the internet with minimal public debate have resulted in the creation of a legal system that raises as many problems as it solves. The regulations as presently notified are arguably unconstitutional, arbitrary and vague and could pose a serious problem to the business of various intermediaries in the country (not to mention hampering internet penetration in the country) and also...
More »EU stamp for Darjeeling Tea by Vivek Chhetri
The European Commission has registered Darjeeling Tea as a Protected Geographic Indication (PGI) product — the first commodity from India to get such a tag. The status implies that the brew produced only in Darjeeling can be sold as Darjeeling Tea in the European Union countries. But a section of blenders, who at present pass off brew with a certain percentage of Darjeeling brew as Darjeeling Tea, have been given a...
More »‘Poverty is a human rights violation' by J Venkatesan
Prof. Thomas Pogge of Yale University on Tuesday strongly advocated the need for global institutional reforms to eradicate poverty, ensure human rights and secure global justice. He suggested establishing a Health Impact Fund (HIF) to complement the Trade-Related Aspects of Intellectual Property Rights (TRIPS). Prof. Pogge made these observations while delivering the First Dr. Arjun K. Sengupta Memorial Lecture at O. P. Jindal Global University in Sonepat near Delhi. Prof. Pogge said:...
More »